Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

21:21 EDT 30th July 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 8,000+

Monday 28th July 2014

Brazilian researchers identify RNA that regulates cell death

(Fundação de Amparo à Pesquisa do Estado de São Paulo) Researchers from the University of Sao Paulo have identified an RNA known as INXS that modulates the action of an important gene in the process of programmed cell death. In experiments on mic...

Study tracks worldwide spread of beneficial blood cell gene variant

(King's College London) Two beneficial variants of a gene controlling red blood cell development have spread from Africa into nearly all human populations across the globe, according to a new study led by King's College London. The international team...

23andMe scientists receive approximately $1.4 million in funding from National Institutes of Health

(23andMe Inc.) 23andMe, the leading personal genetics company, has received from the National Institutes of Health a grant totaling $1,367,504 for a two-year project to support the further development of 23andMe's web-based database and research engi...

Scientists to study hereditary breast cancer to find BRCA1 treatment

(Virginia Tech) People with a BRCA1 gene mutation are at much higher risk for breast cancer, but no treatments exist to specifically target this problem. Researchers will use structural biology tools to better understand this difficult-to-treat hered...

Charon to receive 2014 Gene D. Cohen Award

(The Gerontological Society of America) The Gerontological Society of America and the National Center for Creative Aging have chosen Rita Charon, MD, PhD, of Columbia University as the 2014 recipient of the Gene D. Cohen Research Award in Creativity...

Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide

Introducing Updated Version of The Brain Health Guide with the Latest Brain Health Tips Madison, WI (PRWEB) July 28, 2014 Quincy Bioscience, makers of the nation’s leading memory supplement Prevagen®, is pleased to announce the release of the fourth edition of The Brain Health Guide, written by company president and co-founder Mark Underwood. The Brain Health Guide is a unique resource for...

Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells

Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in the U.S. die each year from metastatic breast and prostate cancers – an aggressive form of the disease that occurs when the cancer has spread to other parts of the body, such as the lungs, liver, bones, or brain. Now researchers at Drexel Universit...

DesignMedix closes $1.1mm Series A

DesignMedix Inc. (developing antimalarials and antibacterials) closed a $1.1mm Series A financing. The Oregon Angel Fund, Angel Oregon 2009 LLC, Northwest Technology Ventures, Women’s Investment Network, and seven private investors participated. Th...

Researchers discover cool-burning flames in space, could lead to better engines on earth

A team of international researchers has discovered a new type of cool burning flames that could lead to cleaner, more efficient engines for cars. The discovery was made during a series of experiments on the International Space Station by a team led b...

'Biological basis' for schizophrenia uncovered in gene study

More than 100 genetic regions have been found to be involved in schizophrenia, many of which were not previously linked to the condition...

Boehringer, Zealand Pharma focus on cardio-metabolic diseases in new drug discovery deal

Danish peptide-based drug developer Zealand Pharma A/S (CPH:ZEAL) and German Boehringer Ingelheim have signed a worldwide exclusive licence, research and development deal for the development of novel therapies of patients...

Genetics Involved with Menarche May Hold Keys to Preventing Diabetes or Osteoporosis in Later Life

(News-Medical) – A novel study shows that the age girls reach puberty is influenced by ‘imprinted genes’-a subset of genes whose activity differs depending on which parent contributes the gene. This is the first evidence that imprin...

Cancer researchers identify irreversible inhibitor for KRAS gene mutation

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

Xention awarded $2.4M from Technology Strategy Board for atrial fibrillation medicines

Xention, a Cambridge-based biopharmaceutical company specializing in the discovery and development of ion channel-modulating drugs, was awarded $2.4 million from the Technology Strategy Board, a U.K. innovation agency, to progress its novel IKAChchan...

Irreversible inhibitor for KRAS gene mutation involved in lung, colon, and pancreatic cancers

Cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

Researchers produce record-length mirror-image protein

Biochemists have reported an advance in the production of functional mirror-image proteins. In a new study, they have chemically synthesized a record-length mirror-image protein and used this protein to demonstrate that a cellular chaperone, which he...

PPD Adds Customer-Focused Strategic Leader to Drive Client Success

Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Henry Levy as executive vice president of client development and commercial services. Levy leads PPD’s customer-facing teams to optimize strategies and deliver results through cross-functional collaboration across the full range of

Scientists find genetic mutations linked to salivary gland tumors

Research conducted at the Florida campus of The Scripps Research Institute (TSRI) has discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands. The discovery c...

VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds for Prevention of Mosquito-Borne Illnesses

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), a leading non-profit biomedical research institute, today announced a key milestone achievement in developing novel approaches for the prevention of mosquito-borne viral threats, including chikungunya and dengue fever, diseases that are currently epidemic in tropical regions of the world...

PLXNA4 gene may increase risk of developing Alzheimer's disease

Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options th...

OHSU Knight Cancer Challenge attracts $100 million gift

PORTLAND, Ore., July 28, 2014 /PRNewswire/ -- Oregon Health & Science University's Knight Cancer Institute has received a $100 million gift to fuel its ambitious vision to stop cancer in its tracks. A donor, who wishes to remain unnamed, pledged the funds as part of OHSU's unprecedented $1 billion campaign to support the Knight Cancer Institute's initiative to revolutionize the early d...

MC10 Inc. & UCB Partner for Innovative Solutions for Patients with Neurological Disorders.

Technology company MC10 Inc. and global biopharmaceutical company UCB announced that they have entered into a partnership to develop

The Overtreatment Conundrum: Definiens Identifies Three Steps for Advancing Diagnostics to Reduce Unnecessary Cancer Treatment and Improve Patient Health

Definiens, the global leader in Tissue Phenomics™ for diagnostics development in oncology, today released tips for the development of diagnostics to help physicians make more informed decisions, reduce unnecessary treatment and improve overall patient health. As the global cost of cancer care continues to rise exponentially, tests based on data generated...

Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014

-- Company to present pre-clinical data and early clinical observations from Phase 1 study of EPZ-6438 (E7438) at ASH Lymphoma meeting on August 12, 2014 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it w...

Studies Presented at World Transplant Congress Support Development of Biomarker Tests Aimed at Improving Transplant Recipient Care

Transplant Genomics Inc. Leads Development of Noninvasive Serial Monitoring Guided by Genomics Studies by the founding scientists of Transplant Genomics Inc. (TGI) to be presented this week at the World Transplant Congress (WTC) are helping lay the groundwork for the company’s development of genomic biomarkers for transplant graft status. The studies...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks